The Magazine for Sleep Professionals
Thursday, May 7, 2026
Nexalin Technology, Inc. announced continued advancement toward its planned pivotal clinical trial evaluating HALO™ Clarity for the treatment of moderate to severe insomnia, designed to support Nexalin’s planned de novo submission to the U.S. Food and Drug Administration. The study is being conducted in collaboration with Lindus Health, a full-service clinical […]
Idorsia Ltd announces that its novel treatment for insomnia disorder QUVIVIQ (Daridorexant) has been awarded the inaugural Prix Galien Bridges Award in the category of “Best Biotechnology & Pharmaceutical Product”. The award recognizes groundbreaking medicines, including biologics, gene therapies, and traditional pharmaceutical compounds, that advance patient care through scientific innovation. […]
Social media trends have become increasingly influential – even changing bedtime routines and sleep habits for many Americans. According to a 2025 survey from the American Academy of Sleep Medicine, 56% of U.S. adults have tried one of this year’s viral social media trends related to sleep. “Bed rotting,” which is […]
SleepSpace (Proactive Life, Inc.), an AI-powered sleep technology company founded by NIH-funded sleep scientist Dr. Daniel Gartenberg, PhD, announced today it has been awarded a Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). The award supports development […]
An estimated one in three adults worldwide experience symptoms of insomnia, yet only a fraction of those suffering have access to specialists trained in cognitive behavioral therapy for insomnia (CBTI)—the gold standard in treatment.1,2 This unmet need has created a major bottleneck in behavioral sleep medicine, where demand far exceeds […]
Millions of people worldwide who suffer with chronic insomnia are all too familiar with its profound impact on cognitive function, mood, and overall health and well-being. Many of these patients have success with first-line treatments like cognitive behavioral therapy (CBT) and pharmacological interventions, but relief remains elusive for many with […]
Specific types of gut bacteria may increase or decrease the risk for insomnia, while insomnia itself may in turn alter the abundance of certain gut bacteria, a new study showed. However, outside experts challenged the investigators’ assertion that the link is causal. Investigators identified 14 groups of bacteria associated with increased […]
Topline: Patients with type 2 diabetes (T2D) who experienced sleep impairments, including short sleep duration, snoring, and insomnia symptoms, were more likely to face an increased risk for diabetes distress. In particular, daytime coping difficulties due to sleep problems showed a notably prominent association with diabetes distress. Methodology: Researchers in Norway conducted a cross-sectional […]
Sleep apnea and insomnia are two of the most prevalent sleep disorders, often coexisting and compounding the burden on patients’ quality of life. For sleep professionals, the challenge lies in unraveling the intertwined pathology of these conditions to provide effective treatment. Given this complex interplay, it is crucial to identify […]
Insomnia is a prevalent, impactful, and costly sleep condition. Prevalence of insomnia symptoms across Europe, Canada, and the United States range from 24.8% to 40%. Disrupted sleep is seen across development and age—from infants to older adults. Medical conditions and life changes affect sleep, such as pregnancy and menopause, and […]
